Literature DB >> 12591228

Decrease in fibrin content of venous thrombi in selectin-deficient mice.

V V Sullivan1, A E Hawley, D M Farris, B S Knipp, A J Varga, S K Wrobleski, P Thanapron, M J Eagleton, D D Myers, J B Fowlkes, T W Wakefield.   

Abstract

The purpose of this study was to quantify the fibrin content of thrombi produced in a mouse model of venous thrombosis and correlate this to thrombus mass. The role of P-selectin, E-selectin, and IL-10 on thrombus fibrin content was analyzed using knockout (KO) mice. Five groups of mice were evaluated: control (N = 10), P-selectin KO (N = 7), E-selectin KO (N = 5), combined E-/P-selectin KO (N = 12), and IL-10 KO (N = 10). Venous thrombosis was induced by ligation of the infrarenal IVC. Mice were sacrificed on postoperative days (POD) 2 and 6. Thrombus mass was calculated. Sections of IVC were stained with an antibody that cross reacts with mouse fibrin. The distribution of RGB color pixels was generated from digitized micrographs of the thrombus of each animal. The mean pixel value for each group was compiled and analyzed using 2-way ANOVA. Mean pixel value per group was correlated with the mean thrombus mass per group. Color analysis demonstrated significant decreases in the analyzed fibrin content on POD-2 between the control vs E-/P-selectin KO (P < 0.05) and control vs IL-10 KO (P < 0.05) groups. In addition, significantly less fibrin staining was noted on POD-6 between the control vs E-selectin KO (P = 0.03), control vs P-selectin KO (P = 0.01), and control vs E-/P-selectin KO (P < 0.01). There was a strong overall correlation between the mean pixel value for each group and the thrombus mass (R = 0.964; P < 0.01). This study demonstrates a difference in fibrin content of thrombi produced in animals deficient in E-selectin, P-selectin, and IL-10, supporting their importance in thrombus amplification, fibrin formation, and the mass of thrombus formed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591228     DOI: 10.1016/s0022-4804(02)00041-0

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  17 in total

1.  The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis.

Authors:  Beste Ozben; Reyhan Diz-Kucukkaya; Ahmet K Bilge; Veysel S Hancer; Aytac Oncul
Journal:  J Thromb Thrombolysis       Date:  2007-06       Impact factor: 2.300

Review 2.  Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Authors:  Allan K Metz; Jose A Diaz; Andrea T Obi; Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

3.  Clinical and histopathological review of 229 cases of ranula.

Authors:  Yulin Jia; Yifang Zhao; Xinming Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

4.  Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.

Authors:  Jose A Diaz; Nicole E Ballard-Lipka; Diana M Farris; Angela E Hawley; Shirley K Wrobleski; Daniel D Myers; Peter K Henke; Daniel A Lawrence; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2011-11-25       Impact factor: 4.268

5.  Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis.

Authors:  Andrea T Obi; Elizabeth Andraska; Yogendra Kanthi; Catherine E Luke; Megan Elfline; Suresh Madathilparambil; Teruna J Siahaan; Farouc A Jaffer; Thomas W Wakefield; Krishnan Raghavendran; Peter K Henke
Journal:  J Vasc Res       Date:  2016-10-22       Impact factor: 1.934

6.  P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.

Authors:  Jose A Diaz; Shirley K Wrobleski; Christine M Alvarado; Angela E Hawley; Nichole K Doornbos; Patrick A Lester; Suzan E Lowe; Joy E Gabriel; Karen J Roelofs; Peter K Henke; Robert G Schaub; Thomas W Wakefield; Daniel D Myers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02-05       Impact factor: 8.311

7.  Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery.

Authors:  Ian J Welsby; Mihai V Podgoreanu; Barbara Phillips-Bute; Richard Morris; Joseph P Mathew; Peter K Smith; Mark F Newman; Debra A Schwinn; Mark Stafford-Smith
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-01-06       Impact factor: 2.628

8.  Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.

Authors:  Daria K Moaveni; Erin M Lynch; Cathy Luke; Vikram Sood; Gilbert R Upchurch; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

9.  NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis.

Authors:  Yi-Dan Li; Bu-Qing Ye; Sheng-Xi Zheng; Jin-Tao Wang; Jian-Guo Wang; Ming Chen; Ji-Guo Liu; Xin-Hui Pei; Li-Jing Wang; Zhi-Xin Lin; Kalpna Gupta; Nigel Mackman; Arne Slungaard; Nigel S Key; Jian-Guo Geng
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

10.  Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

Authors:  Robert A Campbell; Katherine A Overmyer; Craig H Selzman; Brett C Sheridan; Alisa S Wolberg
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.